Monitoring engraftment of donor haematopoietic cells post transplant may be carried out through donor and patient genotyping using short tandem repeat (STR) markers. In the reduced-intensity conditioning (RIC) transplant setting, sublineage chimaerism has been shown to be a useful tool in monitoring engraftment, predicting relapse and guiding immunotherapy (such as donor lymphocyte infusions). 1 Recently, there has been much interest surrounding the potential development of donor-derived haematopoietic cells in non-haematopoietic tissue following allogeneic haematopoietic SCT (HSCT). By performing chimaerism studies on isolated non-haematopoietic tissue such as fingernail or hair follicle samples, several groups have demonstrated the presence of mixed donor-recipient chimaerism in fingernail samples of patients who had undergone conventional myeloablative HSCT. 2, 3 Clinical effects of myeloablative HSCT often include significant tissue inflammation and damage, and it has been hypothesized that these conditions may facilitate the engraftment of donor-derived stem cells in non-haematopoietic tissue. 2 It remains unclear at present whether similar patterns of mixed donor chimaerism may be found in patients undergoing non-myeloablative conditioning regimens.
We report herein on the results of eight sets of matched fingernail and peripheral blood (PB) chimaerism studies performed on adult patients undergoing allogeneic HSCT (Table 1) . Two patients received conventional myeloablative conditioning and six received an RIC transplant for a range of haematological malignancies (myelodysplastic syndrome, AML). The median age of the patients at transplant was 51 years (range: 28-66 years) and four patients had prior cutaneous GVHD. The median time of fingernail chimaerism sampling was 1048 days post-HSCT (range: 68-3353 days). None of the patients had active GVHD at time of sampling, and there was no abnormalities in the growth and appearance of fingernails in any of the patients tested, or any evidence of recent trauma or bleeding.
DNA was isolated from donor and recipient pretransplant PB using a DNA-binding column method (Qiagen Ltd, Crawley, UK) and used as control samples. Fingernail samples were obtained from 10 fingers of each recipient with a new nail cutter used for each patient. Following overnight proteinase digestion the supernatant from the fingernail sample was removed and DNA was extracted using the same column method. Chimaerism was assessed in isolated PB CD3 þ T cell and CD15 þ granulocyte populations as previously described. 1 Briefly, 15 polymorphic STR loci (Penta E, D18S51, D21S11, TH01, D3S1358, FGA, TPOX, D8S1179, vWA, Penta D, CSF1PO, D16S539, D7S820, D13S317 and D5S818) plus the sex-determining Amelogenin loci (PowerPlex, Promega Corp., Madison, WI, USA) were amplified to provide a genetic profile for pre-transplant donor and recipient samples. Informative alleles were identified and used to assess donor engraftment. The samples were electrophoresed using PAGE on an ABI Prism 377 DNA sequencer and analysed using Genescan 2.0 software (Applied Biosystems, Foster City, CA, USA). Quantification was carried out using the area under the peaks, and following cell dilution studies the sensitivity of this methodology is approximately 5%. Full donor chimaerism has been defined as the presence of495% donor haematopoietic cells, whereas mixed donor chimaerism encompasses a wide range of 5-95% donor cells post transplant. 4 Of the eight patients studied, one of the two patients who received conventional myeloablative conditioning and three of the six receiving RIC transplants had detectable levels of mixed donor chimaerism in the fingernail samples. The median level of donor chimaerism in the fingernail samples of these patients was 22% (range: 14-58%). There was no correlation between the absolute values of chimaerism in the fingernail sample and that in unfractionated PB, CD3 (T cell) or CD15 (granulocyte) fractions from the same time point, as evidenced by the fact that three of the four patients with mixed fingernail donor chimaerism were full donor chimaeric in the PB. In addition, no correlation was found between fingernail donor chimaerism and time of sampling post transplant. Of the six patients receiving RIC, all three with evidence of mixed donor chimaerism had prior cutaneous GVHD that was quiescent at time of sampling.
Recently Hong et al. 3 have presented data illustrating complete recipient chimaerism in the hair follicles of 29 patients following myeloablative transplant. This suggests that donor haematopoietic cells do not develop in hair follicles. Conversely, Imanishi et al. 2 provided evidence that mixed chimaerism exists in fingernail samples of patients undergoing myeloablative HSCT. In addition, they compared data on mixed chimaerism with clinical findings and reported no correlation between donor-derived chimaerism in non-haematopoietic tissue and GVHD in skin. 2 Our investigations are the first to describe donor-derived cells present in non-haematopoietic tissue from patients who have undergone RIC HSCT. Although the clinical significance of these findings is unclear, this finding suggests that other factors, in addition to the dose-related cytotoxicity associated with allogeneic transplant conditioning, may dictate the presence of donor-derived non-haematopoietic cell chimaerism in these patients. It is of note that all three patients with mixed fingernail chimaerism had preceding cutaneous GVHD, and it is possible that that the local inflammation and tissue damage induced by GVHD may facilitate the engraftment of donor haematopoietic stem cells in the nail bed. Our report is observational, and further investigations, both in the myeloablative and RIC settings, are required to confirm these results and perhaps unravel some of the mechanisms of donor stem cell engraftment in non-haematopoietic tissue following HSCT. M  RIC  315  58  86  35  100  2  50  F  RIC  2297  18  100  100  100  3  47  M  STD  1413  14  100  100  100  4  66  M  RIC  68  24  100  89  100  5  28  M  STD  677  0  100  81  100  6  59  M  RIC  160  0  100  100  100  7  51  F  RIC  3353  0  100  ND  ND  8  53  M  RIC  97  0  61  19  92 Abbreviations: F ¼ female; M ¼ male; ND ¼ not done; PB ¼ peripheral blood; RIC ¼ reduced-intensity conditioning; STD ¼ standard myeloablative conditioning.
